Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about
Vitruvias Pharmaceuticals completes Series A round
January 08, 2018
The Auburn-based pharmaceutical has completed a multimillion-dollar investment round.
Tags
Arbor Pharmaceuticals
Michael Altman
Ed Schutter
From
Business Journals
Owner of 3 Colorado RV dealerships is being sold
October 30, 2017
The company bought Colorado's RV America in 2015.
Tags
ANDA
Don Wallace
Travel & Tourism
From
Business Journals
Lazydays sells for $115 million
October 28, 2017
The sale means the company will soon become publicly traded.
Tags
EarlyBirdCapital
Private equity
Scientific Games Corp
From
Business Journals
BRIEF-Andina Acquisition Corp II says to acquire Lazydays R.V. Center Inc
October 27, 2017
* Andina Acquisition Corp. II announces agreement to acquire Lazydays R.V. Center, Inc.
Tags
companyNews
From
Reuters: Company News
BRIEF-Andina Acquisition Corp II obtains extension to complete business combination
May 12, 2017
* Andina Acquisition Corp. II obtains extension to complete business combination
Tags
companyNews
From
Reuters: Company News
A Timeline Of Teva's M&A Over The Past Year
August 03, 2016
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) and Allergan plc (NYSE: AGN) disclosed Wednesday they reached an agreement ...
Tags
Biotech
AGN
TEVA
From
Benzinga
Lannet Company Announces FDA Approval Of Nasal Spray, Shares Tick Higher
February 22, 2016
Shares of Lannet Company, Inc. (NYSE: LCI) were trading higher by more than 1 percent on Monday after the company announced that it has ...
Tags
FDA
Imitrex
Movers
From
Benzinga
Supernus Up 3.7%, Federal Court Says Actavis Is Infringing On Patents
February 08, 2016
Supernus Pharmaceuticals Inc (NASDAQ: SUPN), a specialty pharmaceutical company that develops treatments for central nervous system ...
Tags
Intraday Update
Oxtellar XR
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.